Clinical Trials Browser

Interventional × Sarcoma, Kaposi × Sorafenib × Clear all

NCT00287495 2019-12-12

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

Phase 1 Terminated

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi